Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 4 51-4, 2005, Pages

  Matusiak, Damien ^a   Glover, Sarah ^a   Nathaniel, Rajkumar ^a   Matkowskyj, Kristina ^a   Yang, Jianxin ^a   Benya, Richard V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bombesin; Colon cancer; Gastrin releasing peptide receptor; Keyhole limpet hemocyanin; Proliferation

Indexed keywords

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; MITOGENIC AGENT; NEUROMEDIN B;

ARTICLE; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; COLON; COLONIC NEOPLASMS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MITOGENS; NEUROKININ B; RECEPTORS, BOMBESIN; RNA, MESSENGER;

EID: 15244346716     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00156.2004     Document Type: Article

References (42)

1. Bartholdi MF, Wu JM, Pu H, Troncoso P, Eden PA, and Feldman RI. In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. Int J Cancer 79: 82-90, 1998.
2. Benya RV, Kusui T, Pradhan TK, Battey JF, and Jensen RT. Expression and characterization of cloned human bombesin receptors. Mol Pharmacol 47: 10-20, 1995.
3. Benya RV, Wada E, Battey JF, Fathi Z, Wang LH, Mantey S, Coy DH, and Jensen RT. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine proteins, signal transduction, and comparison with natively expressed receptors. Mol Pharmacol 42: 1058-1068, 1992.
4. Burghardt B, Wenger C, Barabas K, Racz G, Olah A, Flautner L, Coy DH, Gress TM, and Varga G. GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF. Peptides 22: 1119-1128, 2001.
5. Cardona C, Rabbitts PH, Spindel ER, Ghatei MA, Bleehen NM, Bloom SR, and Reeve JG. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines. Cancer Res 51: 5205-5011, 1991.
6. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, and Benya RV. Aberrant expression of gastrin-releasing peptide and its receptor by well differentiated colon cancers in humans. Am J Physiol Gastrointest Liver Physiol 276: G655-G665, 1999.
7. Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF, and Benya RV. Gastrin-releasing peptide is a mitogen and morphogen in murine colon cancer. Cell Growth Differ 11: 385-393, 2000.
8. Cassano GRN, Gasparre G, Lippe C, Guanti G. The proliferative response of HT-29 human colon adenocarcinoma cells to bombesin-like peptides. Cancer Lett 172: 151-157, 2001.
9. Chave HS, Gough AC, Palmer K, Preston SR, and Primrose JN. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer 82: 124-130, 2000.
10. Coy DH, Jensen RT, Jiang NY, Lin JT, Bogden AE, and Moreau JP. Systematic development of bombesin/gastrin-releasing peptide antagonists. J Natl Cancer Inst Monogr 13: 133-139, 1992.
11. Coy DH, Mungan Z, Rossowski WJ, Cheng BL, Lin JT, Mrozinski JEJ, and Jensen MT. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat. Peptides 13: 775-781, 1992.
12. De La Fuente M, Del Rio M, and Hernanz A. Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: involvement of cyclic AMP, inositol 1,4,5-trisphosphate and protein kinase C. Ann Oncol 4: 499-507, 1993.
13. Erspamer V. Discovery, isolation and characterization of bombesin-like peptides. Ann NY Acad Sci 547: 3-9, 1988.
14. Frucht H, Gazdar AF, Park JA, Oie H, and Jensen RT. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52: 1114-1122, 1992.
15. Giacchetti S, Gauville C, De Cremoux P, Bertin L, Berthon P, Abita JP, Cuttitta F, and Calvo F. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J Cancer 46: 293-298, 1990.
16. Giaccone G, Battey J, Gazdar AF, Oie H, Draoui M, and Moody TW. Neuromedin B is present in lung cancer cell lines. Cancer Res 52, Suppl 9: 2732s-2736s, 1992.
17. Glover S, Delaney M, Dematte C, Kornberg L, Frasco M, Tran-Son-Tay R, and Benya RV. Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties. J Cell Physiol 199: 77-88, 2004.
18. Gugger M and Reubi JC. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 155: 2067-2076, 1999.
19. Jensen JG, Carroll RE, and Benya RV. The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 22: 689-699, 2001.
20. Kusui T, Benya RV, Battey JF, and Jensen RT. Glycosylation of bombesin receptors: characterization, effect on binding, and G protein coupling. Biochemistry 33: 12968-12980, 1994.
21. Malendowicz LK, Macchi C, Nussdorfer GG, and Nowak M. The role of neuromedin B in the regulation of rat pituitary-adrenocortical function. Histol Histopathol 11: 895-897, 1996.
22. Mantey S, Frucht H, Coy DH, and Jensen RT. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mol Pharmacol 45: 762-774, 1993.
23. Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, and Jensen RT. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem 272: 26062-26071, 1997.
24. Matkowskyj KA, Cox R, Jensen RT, and Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures protein concentration. J Histochem Cytochem 51: 205-214, 2003.
25. Matkowskyj KA, Schonfeld D, and Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab. J Histochem Cytochem 48: 303-311, 2000.
26. Moody TW, Chan D, Fahrenkrug J, and Jensen RT. Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des 9: 495-509, 2003.
27. Moyer MP, Stauffer J, Manzano L, Tanzer L, and Merriman R. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32: 315-317, 1996.
28. Rettori V, Pazos-Moura CC, Moura EG, Polak J, and McCann SM. Role of neuromedin B in control of the release of thyrotropin in hypothyroid and hyperthyroid rats. Proc Natl Acad Sci USA 89: 3035-3039, 1992.
29. Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, and Shriver SP. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pulm Pharmacol Ther 12: 291-302, 1999.
30. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, and Marra MA (Mammalian Gene Collection Program Team). Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl Acad Sci USA 99: 16899-16903, 2002.
31. Sun B, Halmos G, Schally AV, Wang X, and Martinez M. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. Prostate 42: 295-303, 2000.
32. Sun B, Schally AV, and Halmos G. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul Pept 90: 77-84, 2000.
33. Traynor TR and O'Grady SM. Regulation of colonic ion transport by GRP. I. GRP stimulates transepithelial K and Na secretion. Am J Physiol Cell Physiol 270: C848-C858, 1996.
34. Traynor TR and O'Grady SM. Regulation of colonic ion transport by GRP. II. GRP modulates the epithelial response to PGE2. Am J Physiol Cell Physiol 270: C859-C865, 1996.
35. Tsuda T, Kusui T, and Jensen RT. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton. Biochemistry 36: 16328-16337, 1997.
36. Von Schrenck T, Heinz-Erian P, Moran T, Mantey SA, Gardner JD, and Jensen RT. Neuromedin B receptors in the esophagus: evidence for subtypes of bombesin receptors. Am J Physiol Gastrointest Liver Physiol 256: G747-G758, 1989.
37. Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, and Battey J. cDNA cloning, characterization, and brain region-specific expression of a neuromedin B-preferring bombesin receptor. Neuron 6: 421-430, 1991.
38. Yamada K, Santo-Yamada Y, Wada E, and Wada K. Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice. Mol Psychiatry 7: 113-117, 2002.
39. Yamada K, Santo-Yamada Y, and Wada K. Restraint stress impaired maternal behavior in female mice lacking the neuromedin B receptor (NMB-R) gene. Neurosci Lett 330: 163-166, 2002.
40. Yamada K, Wada E, Santo-Yamada Y, and Wada K. Bombesin and its family of peptides: prospects for the treatment of obesity. Eur J Pharmacol 440: 281-290, 2002.
41. Yamada K, Wada E, Yamano M, Sun YJ, Ohara-Imaizumi M, Nagamatsu S, and Wada K. Decreased marble burying behavior in female mice lacking neuromedin-B receptor (NMB-R) implies the involvement of NMB/NMB-R in 5-HT neuron function. Brain Res 942: 71-78, 2002.
42. Yegen BC. Bombesin-like peptides: candidates as diagnostic and therapeutic tools. Curr Pharm Des 9: 1013-1022, 2003.